| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 16. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | dibotermin alfa (InductOs®) |
| Formulation | 1.5 mg/ml powder, solvent and matrix for implantation matrix |
| Reference number | 2602 |
| Indication | For single-level lumbar interbody spine fusion as a substitute for autogenous bone graft in adults with degenerative disc disease who have had at least 6 months of non-operative treatment for this condition |
| Company | Medtronic BioPharma B.V. |
| BNF chapter | Musculoskeletal & joint diseases |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 28/01/2015 |